Cyprumed, MSD Sign Deal for Oral Peptide Therapeutics
Cyprumed GmbH, a dedicated drug delivery company specializing in innovative oral peptide formulations, and MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA), today...
Tag : Research
ASCO GU: Veracyte’s Decipher Tests Boost Cancer Care, Research
Study showing that Decipher GRID-derived PORTOS signature predicts benefit from dose-escalated radiation therapy also published in Annals of Oncology Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics...